608 related articles for article (PubMed ID: 19930051)
1. Arterial occlusion sites on magnetic resonance angiography influence the efficacy of intravenous low-dose (0.6 mg/kg) alteplase therapy for ischaemic stroke.
Nakashima T; Toyoda K; Koga M; Matsuoka H; Nagatsuka K; Takada T; Naritomi H; Minematsu K
Int J Stroke; 2009 Dec; 4(6):425-31. PubMed ID: 19930051
[TBL] [Abstract][Full Text] [Related]
2. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.
Derex L; Nighoghossian N; Hermier M; Adeleine P; Berthezène Y; Philippeau F; Honnorat J; Froment JC; Trouillas P
J Neurol Sci; 2004 Oct; 225(1-2):3-9. PubMed ID: 15465079
[TBL] [Abstract][Full Text] [Related]
3. Early carotid endarterectomy after intravenous thrombolysis for acute ischaemic stroke.
Bartoli MA; Squarcioni C; Nicoli F; Magnan PE; Malikov S; Berger L; Lerussi GB; Branchereau A
Eur J Vasc Endovasc Surg; 2009 May; 37(5):512-8. PubMed ID: 19231256
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
Koga M; Arihiro S; Miyashita F; Yamamoto H; Yamada N; Nagatsuka K; Minematsu K; Toyoda K
Cerebrovasc Dis; 2013; 36(4):299-305. PubMed ID: 24135558
[TBL] [Abstract][Full Text] [Related]
5. MRI-based score for acute basilar artery thrombosis.
Renard D; Landragin N; Robinson A; Brunel H; Bonafe A; Heroum C; Milhaud C
Cerebrovasc Dis; 2008; 25(6):511-6. PubMed ID: 18480603
[TBL] [Abstract][Full Text] [Related]
6. MRI in patients with acute basilar artery occlusion - DWI lesion scoring is an independent predictor of outcome.
Nagel S; Herweh C; Köhrmann M; Huttner HB; Poli S; Hartmann M; Hähnel S; Steiner T; Ringleb P; Hacke W
Int J Stroke; 2012 Jun; 7(4):282-8. PubMed ID: 22151607
[TBL] [Abstract][Full Text] [Related]
7. [Prospects of thrombolytic therapy for acute ischemic stroke].
Nakashima T; Minematsu K
Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
[TBL] [Abstract][Full Text] [Related]
8. SYNTHESIS expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fast-track endovascular treatment vs. standard intravenous alteplase for acute ischemic stroke.
Ciccone A; Valvassori L; Nichelatti M;
Int J Stroke; 2011 Jun; 6(3):259-65. PubMed ID: 21557814
[TBL] [Abstract][Full Text] [Related]
9. Computed tomography and computed tomography angiography findings predict functional impairment in patients with minor stroke and transient ischaemic attack.
Coutts SB; O'Reilly C; Hill MD; Steffenhagen N; Poppe AY; Boyko MJ; Puetz V; Demchuk AM;
Int J Stroke; 2009 Dec; 4(6):448-53. PubMed ID: 19930054
[TBL] [Abstract][Full Text] [Related]
10. Impact of admission glucose and diabetes on recanalization and outcome after intra-arterial thrombolysis for ischaemic stroke.
Arnold M; Mattle S; Galimanis A; Kappeler L; Fischer U; Jung S; De Marchis GM; Gralla J; Mono ML; Brekenfeld C; Meier N; Nedeltchev K; Schroth G; Mattle HP
Int J Stroke; 2014 Dec; 9(8):985-91. PubMed ID: 22973986
[TBL] [Abstract][Full Text] [Related]
11. Early recanalization rate of major occluded brain arteries after intravenous tissue plasminogen activator therapy using serial magnetic resonance angiography studies.
Kimura K; Iguchi Y; Shibazaki K; Aoki J; Uemura J
Eur Neurol; 2009; 62(5):287-92. PubMed ID: 19713704
[TBL] [Abstract][Full Text] [Related]
12. Clinical, biochemical and neuroimaging parameters after thrombolytic therapy predict long-term stroke outcome.
Brouns R; Sheorajpanday R; Kunnen J; De Surgeloose D; De Deyn PP
Eur Neurol; 2009; 62(1):9-15. PubMed ID: 19407450
[TBL] [Abstract][Full Text] [Related]
13. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke.
Miedema I; Uyttenboogaart M; Koopman K; De Keyser J; Luijckx GJ
Cerebrovasc Dis; 2010 Feb; 29(3):263-7. PubMed ID: 20090317
[TBL] [Abstract][Full Text] [Related]
14. Factors predicting outcome in stroke patients treated with 0.6 mg/kg alteplase: evidence from the Japan Alteplase Clinical Trial (J-ACT).
Mori E; Minematsu K; Nakagawara J; Yamaguchi T;
J Stroke Cerebrovasc Dis; 2011 Nov; 20(6):517-22. PubMed ID: 20719535
[TBL] [Abstract][Full Text] [Related]
15. Intravenous alteplase at 0.6 mg/kg for acute stroke patients with basilar artery occlusion: the stroke acute management with urgent risk factor assessment and improvement (SAMURAI) Recombinant tissue plasminogen activator registry.
Miyagi T; Koga M; Shiokawa Y; Nakagawara J; Hasegawa Y; Furui E; Kimura K; Kario K; Okuda S; Yamagami H; Okada Y; Nezu T; Maeda K; Endo K; Minematsu K; Toyoda K
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1098-106. PubMed ID: 23063059
[TBL] [Abstract][Full Text] [Related]
16. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
17. [ASPECTS-DWI, arterial occlusion sites and subtype of acute ischemic stroke have a relation with outcome following intravenous rt-PA therapy].
Idei M; Sasaki T; Tanabe T; Muraoka K; Terada K; Meguro T; Hirotsune N; Nishino S
No Shinkei Geka; 2012 Jul; 40(7):585-91. PubMed ID: 22728535
[TBL] [Abstract][Full Text] [Related]
18. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
19. Prediction of long-term outcome by percent improvement after the first day of thrombolytic treatment in stroke patients.
Nam HS; Lee KY; Han SW; Kim SH; Lee JY; Ahn SH; Kim DJ; Kim DI; Nam CM; Heo JH
J Neurol Sci; 2009 Jun; 281(1-2):69-73. PubMed ID: 19304298
[TBL] [Abstract][Full Text] [Related]
20. Malignant profile detected by CT angiographic information predicts poor prognosis despite thrombolysis within three hours from symptom onset.
Puetz V; Dzialowski I; Hill MD; Steffenhagen N; Coutts SB; O'Reilly C; Demchuk AM;
Cerebrovasc Dis; 2010; 29(6):584-91. PubMed ID: 20389067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
